Share Email Print
cover

Proceedings Paper • new

Drug-resistant catheter-associated urinary tract Infection (CAUTI): an enlightened therapeutic approach (Conference Presentation)
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Catheter–associated urinary tract infections (CAUTIs) cause millions of infections in the US every year, with direct medical costs exceeding billions of dollars and resulting in > 1 million ER visits and hospitalizations, resulting in thousands of deaths. CAUTI is thought to be a major reservoir both containing and creating highly drug-resistant infections, due to the chronicity of infection, biofilm formation, and the setting of institutionalization with chronic exposure to antibiotics, thus enabling resistance. To reduce antibiotic resistance developing in this setting, we are attempting to apply both antimicrobial photodynamic therapy (aPDT), antimicrobial blue light (aBL), and combinations of both with minimal use of antibiotics. To this end, we established a rat model of UTI. In this model, we catheterized female rats, infected them with a standard uropathogenic E.Coli (UPEC; UTI89), infused the bladder with methylene blue (MB) and potassium Iodide (KI), and illuminated the bladder once with a diffusing fiber connected to a 1W 660nm laser. Multilog killing was observed, but given the transient nature of ROS generation, regrowth of UPEC was seen 24 hours later. To this end, we are experimenting with the combination of illumination with antibiotics. When tetracyclines are illuminated by aBL, we have found > 6 log(10) steps of microbial killing in vitro, and significant drops in the antibiotic MIC effected by the combination of light and drug. Multiple treatments with aBL and aPDT both with and without limited intravesical application of antimicrobials may light the way to solving this problem.

Paper Details

Date Published: 4 March 2019
PDF
Proc. SPIE 10863, Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases II, 108630P (4 March 2019); doi: 10.1117/12.2507562
Show Author Affiliations
Jeffery A. Gelfand, Massachusetts General Hospital (United States)
Yingying Huang, Massachusetts General Hospital (United States)
Anton Wintner, Massachusetts General Hospital (United States)
Timothy A. Brauns, Massachusetts General Hospital (United States)
Patrick C. Seed, Duke Univ. Medical Ctr. (United States)
Rox Anderson, Massachusetts General Hospital (United States)
Michael R. Hamblin, Massachusetts General Hospital (United States)
Tianhong Dai, Massachusetts General Hospital (United States)


Published in SPIE Proceedings Vol. 10863:
Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases II
Tianhong Dai; Jürgen Popp; Mei X. Wu, Editor(s)

© SPIE. Terms of Use
Back to Top